These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37207419)

  • 21. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
    Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
    Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles.
    Zhuang J; Gong H; Zhou J; Zhang Q; Gao W; Fang RH; Zhang L
    Sci Adv; 2020 Mar; 6(13):eaaz6108. PubMed ID: 32258408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitor.
    Shi Z; Chen X; Zhang L; Ding S; Wang X; Lei Q; Fang W
    Biomater Sci; 2018 Sep; 6(10):2582-2590. PubMed ID: 30151542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect
    Li F; Wang Y; Chen WL; Wang DD; Zhou YJ; You BG; Liu Y; Qu CX; Yang SD; Chen MT; Zhang XN
    Theranostics; 2019; 9(20):5886-5898. PubMed ID: 31534526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer.
    Qiu W; Chen R; Chen X; Zhang H; Song L; Cui W; Zhang J; Ye D; Zhang Y; Wang Z
    Int J Nanomedicine; 2018; 13():6809-6827. PubMed ID: 30425490
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
    Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
    Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
    J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
    Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
    J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregation-Induced Emission (AIE) and Magnetic Resonance Imaging Characteristics for Targeted and Image-Guided siRNA Therapy of Hepatocellular Carcinoma.
    Hou YC; Zhang C; Zhang ZJ; Xia L; Rao KQ; Gu LH; Wu YC; Lv ZC; Wu HX; Zuo XL; Li F; Feng H; Xia Q
    Adv Healthc Mater; 2022 Sep; 11(17):e2200579. PubMed ID: 35749736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
    Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
    Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
    Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
    Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pH-Responsive Nanoplatform Based on Fluorescent Conjugated Polymer Dots for Imaging-Guided Multitherapeutics Delivery and Combination Cancer Therapy.
    Wang Y; Xiong X; Zhu Y; Song X; Li Q; Zhang S
    ACS Biomater Sci Eng; 2022 Jan; 8(1):161-169. PubMed ID: 34866394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.